MelaSense is an innovative, low-cost, portable biosensor designed to detect aggressive melanoma using saliva samples. By identifying Notch1 mutations, a marker of melanoma progression, the device provides quick, accurate results with 95% sensitivity and specificity for affordable prices. It addresses a critical healthcare gap in remote, underdeveloped areas where access to traditional diagnostic tools like biopsies and MRIs is limited or unaffordable.

MelaSense’s non-invasive testing, ease of use, and rapid results allow for early detection and timely treatment, significantly improving outcomes for patients. With the potential to transform melanoma detection in regions with scarce resources, MelaSense offers a cost-effective, accessible solution that could make a major impact on global health.